2011
DOI: 10.1016/j.jocn.2011.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Polyethylene glycol (PEG) hydrogel dural sealant and collagen dural graft matrix in transsphenoidal pituitary surgery for prevention of postoperative cerebrospinal fluid leaks

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
29
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(33 citation statements)
references
References 33 publications
(41 reference statements)
0
29
0
1
Order By: Relevance
“…PEG hydrogel dural sealant was approved by the Food and Drug Administration for cranial use in April 2005 in the United States, 17) but has been available for clinical use in Japan only since April 2010. The sealant is widely, safely, and effectively used in various neurosurgical fields such as general craniotomy, 6) posterior fossa reconstruction, 17) spinal surgery, 10) pituitary surgery, 3) and in combina- tion with nonautologous dural plasty materials. 22) The clinical efficacy of PEG hydrogel dural sealant has been reported to be 100% for the prevention of intraoperative CSF leakage during surgery with the Valsalva maneuver.…”
Section: Discussionmentioning
confidence: 99%
“…PEG hydrogel dural sealant was approved by the Food and Drug Administration for cranial use in April 2005 in the United States, 17) but has been available for clinical use in Japan only since April 2010. The sealant is widely, safely, and effectively used in various neurosurgical fields such as general craniotomy, 6) posterior fossa reconstruction, 17) spinal surgery, 10) pituitary surgery, 3) and in combina- tion with nonautologous dural plasty materials. 22) The clinical efficacy of PEG hydrogel dural sealant has been reported to be 100% for the prevention of intraoperative CSF leakage during surgery with the Valsalva maneuver.…”
Section: Discussionmentioning
confidence: 99%
“…The safety and efficacy of dural reconstruction with synthetic collagen-based dural substitutes are well described. 7,25,28,36 The structure of the synthetic collagenbased dural substitute presents a low-pressure surface for CSF absorption, promoting a graft-dura interface and chemical signaling for native fibroblasts providing mechanical scaffolding. 28 Litvack et al 25 reported a CSF leakage rate of 6.7%, as well as a 4.2% postoperative infection rate, when using collagen-based substitutes in 425 consecutive patients.…”
Section: Repair Materialsmentioning
confidence: 99%
“…6,8,9 A wide variety of materials have been used to restore the barrier between CSF and the sphenoid sinus, including fat, bone, cartilage, fascia lata, gelatin foam, polyester-silicone, polyethylene glycol, Vicryl patch (Ethicon, Somerville, New Jersey, USA), lyophilized dura, fibrin glue, cement, collagen fleece, muscle, cellulose, acellular dermal matrix, and mucosal flaps. 8,[10][11][12][13][14][15][16][17][18] No prospective clinical trials comparing these materials exist; however, fat autograft remains as a gold standard to which new materials must be compared. The present series seeks to compare the use of fat graft sella repair and obliteration of the sphenoid sinus, with pie-crust closure using AlloDerm (LifeCell Corp, Woodlands, Keywords ► pituitary adenoma ► acellular dermal matrix ► AlloDerm ► fat autograft ► cerebrospinal fluid leak ► transsphenoidal surgery…”
Section: Introductionmentioning
confidence: 99%